AZTREONAM
SEPSIS CAUSED BY ENTEROBACTER·+57
APP PHARMACEUTI
Indication
Citrobacter peritonitis
*Citrobacter* peritonitis is an uncommon, severe intra-abdominal infection characterized by inflammation of the peritoneal lining caused by facultative anaerobic, gram-negative bacilli of the genus *Citrobacter* (most frequently *Citrobacter freundii* or *Citrobacter koseri*). Read more about Citrobacter peritonitis
7 drugs 7 manufacturers
Drugs that treat it
Common Citrobacter peritonitis therapies.
AZTREONAM
SEPSIS CAUSED BY ENTEROBACTER·+57
APP/PREMIERPRO
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
APP/NOVAPLUS
AZTREONAM
SEPSIS CAUSED BY ENTEROBACTER·+57
APP/FRESENIUS K
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
Hospira
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Citrobacter peritonitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Citrobacter* peritonitis is an uncommon, severe intra-abdominal infection characterized by inflammation of the peritoneal lining caused by facultative anaerobic, gram-negative bacilli of the genus *Citrobacter* (most frequently *Citrobacter freundii* or *Citrobacter koseri*).
This clinical state occurs primarily as a healthcare-associated or opportunistic complication in individuals undergoing peritoneal dialysis, as well as in patients with intra-abdominal pathology, gastrointestinal perforation, or immunosuppression.
Hallmark features include abdominal pain, rebound tenderness, systemic signs of infection such as fever, and cloudy peritoneal effluent exhibiting elevated leukocyte counts.
Due to the organism's propensity for inducible beta-lactamase production and multidrug resistance, these infections carry elevated risks of treatment failure, peritoneal catheter removal, and morbidity.
- nih.gov
*Citrobacter* peritonitis is an uncommon, severe intra-abdominal infection characterized by inflammation of the peritoneal lining caused by facultative anaerobic, gram-negative bacilli of the genus *Citrobacter* (most frequently *Citrobacter freundii* or *Citrobacter koseri*)
- medsci.org
*Citrobacter* peritonitis is an uncommon, severe intra-abdominal infection characterized by inflammation of the peritoneal lining caused by facultative anaerobic, gram-negative bacilli of the genus *Citrobacter* (most frequently *Citrobacter freundii* or *Citrobacter koseri*)
- ispd.org
*Citrobacter* peritonitis is an uncommon, severe intra-abdominal infection characterized by inflammation of the peritoneal lining caused by facultative anaerobic, gram-negative bacilli of the genus *Citrobacter* (most frequently *Citrobacter freundii* or *Citrobacter koseri*)
- nih.gov
This clinical state occurs primarily as a healthcare-associated or opportunistic complication in individuals undergoing peritoneal dialysis, as well as in patients with intra-abdominal pathology, gastrointestinal perforation, or immunosuppression Due to the organism's propensity for inducible beta-lactamase production and multidrug resistance, these infections carry elevated risks of treatment failure, peritoneal catheter removal, and morbidity
- elsevierpure.com
This clinical state occurs primarily as a healthcare-associated or opportunistic complication in individuals undergoing peritoneal dialysis, as well as in patients with intra-abdominal pathology, gastrointestinal perforation, or immunosuppression
- kidney.org
This clinical state occurs primarily as a healthcare-associated or opportunistic complication in individuals undergoing peritoneal dialysis, as well as in patients with intra-abdominal pathology, gastrointestinal perforation, or immunosuppression Hallmark features include abdominal pain, rebound tenderness, systemic signs of infection such as fever, and cloudy peritoneal effluent exhibiting elevated leukocyte counts
- nih.gov
Due to the organism's propensity for inducible beta-lactamase production and multidrug resistance, these infections carry elevated risks of treatment failure, peritoneal catheter removal, and morbidity
Personalize your experience
Follow Citrobacter peritonitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.